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Background:  Postoperative acute kidney injury (AKI) is a significant complication after coronary artery bypass sur-
gery.  Prior coronary angiography increases the likelihood of AKI due to the use of a radiocontrast dye.  This study 
examined the effect of coronary angiography on the postoperative renal function after off-pump coronary artery 
bypass surgery (OPCAB).
Methods:  The records of 110 patients who required OPCAB were reviewed.  These patients also had at least two of 
the following conditions: chronic kidney disease, hypertension, diabetes mellitus, emergency surgery, congestive 
heart failure, age >75 years, hematocrit <30%, a left ventricular ejection fraction <40%, or the use of angiotensin-
converting enzyme inhibitors or angiotensin receptor blockers.  The patients were divided into two groups; coronary 
angiography performed within two days of OPCAB (Control group, n = 55), and coronary angiography performed 
more than two days before OPCAB (Angio group, n = 55).  The serum creatinine (SCr) and serum cystatin C levels 
were measured on the day before surgery, as well as on postoperative days 1, 2, 3 and 7.  The estimated glomerular 
filtration rate (eGFR) was also obtained on those days.  AKI was defined as an increase in Cr ≥50% or ≥0.3 mg/dl 
within 48 hours.
Results:  The postoperative changes in the SCr, cystatin C and eGFR were similar in the two groups. The incidence of 
AKI and renal replacement therapy were similar in the two groups.
Conclusions:  Coronary angiography performed within two days of OPCAB does not affect the postoperative renal 
function.  (Korean J Anesthesiol 2010; 58: 142-147)
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Introduction
    Postoperative acute kidney injury (AKI), which was previously 
termed acute renal failure (ARF), is a serious and common 
complication after a coronary artery bypass graft (CABG). It is 
also associated with increased mortality [1-3], and the use of 
cardiopulmonary bypass (CPB) is the greatest risk factor of AKI 
after CABG [4]. Before CABG, cardiac patients undergo coro-
nary angiography using a radiocontrast dye, which can result in 
contrast-induced nephropathy (CIN). Accordingly, patients who 
had their coronary angiography performed in close proximity 
to surgery were at greater risk of developing postoperative AKI, 
suggesting the need to delay surgery after coronary angiography 
[5]. 
    By avoiding CPB, patients undergoing off-pump CABG 
(OPCAB) can have a different level of risk of developing post-
operative AKI despite their recent exposure to radiocontrast 
dye. However, there is no comprehensive data on the impact 
of the interval between coronary angiography and subsequent 
OPCAB on the postoperative renal function. It is important 
to determine if OPCAB is a safe alternative surgical option for 
patients with recent exposure to radiocontrast dye in terms 
of the development of postoperative AKI in order to avoid an 
unnecessary delay of CABG. This validation would be more 
evident if patients with the known risk factors for CIN, such 
as chronic kidney disease, hypertension, diabetes mellitus, 
emergency surgery, congestive heart failure, age >75 years, low 
hematocrit, left ventricular ejection fraction < 40%, and use of 
angiotensin-converting enzyme inhibitors, are studied [6-8].
    Therefore, this study evaluated retrospectively the impact of 
the interval between preoperative coronary angiography and 
OPCAB on the postoperative renal function in patients, who 
had more than two of these risk factors for CIN. 
Materials and Methods
    After gaining Institutional Review Board approval, the 
re  cords from 110 patients who underwent OPCAB from 
March 1, 2008 to July 31, 2009 at our university hospital were 
reviewed. The demographics, clinical characteristics, co-
morbid conditions, medical treatments, laboratory data, an-
gio  graphic data (including the amount and type of contrast 
used), cardiac procedural data (including its timing in relation 
to the preceding angiography), and peri- and postoperative 
events for all patients undergoing OPCAB were placed into a 
computerized database. The selected patients had coronary 
angiography followed by OPCAB at our institution and had 
at least two of the CIN risk factors (chronic kidney disease, 
hypertension, diabetes mellitus, emergency surgery, congestive 
heart failure, age >75 years, hematocrit <30%, left ventricular 
ejection fraction <40%, use of angiotensin-converting enzyme 
inhibitors or angiotensin receptor blockers). These inclusion 
criteria were used because the incidence of nephropathy 
requiring dialysis after percutaneous coronary intervention is 
higher in patients with more than two CIN risk factors [9]. In 
order to focus more on the impact of exposure to a radiocontrast 
on the postoperative renal function, patients with significant 
preoperative renal dysfunction (defined as serum Cr >1.8 mg/
dl) [10] or who received renal replacement therapy before sur-
gery were excluded. Since CIN develops within 48 hours after 
administering the contrast media [11], two days was used as 
the dividing point for comparison. The patients were divided 
into the following two groups: coronary angiography performed 
within two days of OPCAB (Angio group, n = 55) and coronary 
angiography performed more than two days before OPCAB 
(Control group, n = 55). The timing of surgery was dictated by 
the availability of an operating room slot, convenience and 
willingness of the patient to undergo surgery on a given day, 
rather than by a randomized assignment to a particular day; 
patient clinical condition after angiography; or the findings 
from angiography.  
    All patients received 0.05-0.1 mg/kg morphine intra  muscu-
larly as premedication 1 h before surgery. Upon arrival at the 
operating room, standard monitoring devices were applied. A 
pulmonary artery catheter (PAC, Swan-Ganz CCOmbo CCO/
SvO2
TM, Edwards Lifesciences LLC, Irvine, CA, USA), was in-
serted into the right internal jugular vein and connected to 
an analysis system (Vigilance
TM, Edwards Lifesciences LLC, 
Irvine, CA, USA) for continuous monitoring of the cardiac index 
(CI) and mixed venous oxygen saturation (SvO2). Anesthesia 
was induced with intravenous midazolam (0.03–0.07 mg/
kg) and sufentanil (1.5-2.0 μg/kg) and was maintained with 
sevoflurane (0.8-1.5%) and a continuous infusion of sufentanil 
(0.5-1.5 μg/kg/h). Neuromuscular blockade was achieved by 
administering rocuronium (0.9 mg/kg) and was maintained 
with a continuous infusion of vecuronium (1-2 μg/kg/min). 
Isosorbide dinitrate (0.5 μg/kg/min) was infused in all patients 
throughout the study period. After inducing anesthesia, a 
transesophageal echocardiography probe was inserted to 
assess the global car  diac function and detect newly developing 
segmental wall motion abnormalities. Intravascular volume 
replacement was managed with crystalloid and colloid solutions 
to maintain the pulmonary capillary wedge pressure in the 
range of 8-16 mmHg. During the period of heart displacement, 
the crystalloid solution was infused at a fixed rate of 6–8 ml/
kg, whereas the colloid solution was infused to compensate for 
the amount of blood loss, which was collected in a cell salvage 
device. The salvaged blood was reinfused into the patient before 
the completion of surgery. Hemodynamic management during 
the period of heart displacement and grafting was as follows: 1) 144 www.ekja.org
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maintenance of the mean systemic arterial pressure above 70 
mmHg either with 10-15
o Trendelenburg positioning and/or 
norepinephrine infusion, 2) infusion of milrinone into patients 
with a SvO2 <60% for more than 10 min and/or the development 
of mitral regurgitation ≥grade 3 with a concomitant >30 mmHg 
increase in mean pulmonary arterial pressure. Allogenic 
packed red blood cells were transfused when the hematocrit 
level was <25% at any point within the study period. The central 
temperature, which was measured by a pulmonary artery 
catheter, was maintained above 36
oC using a warm mattress, a 
forced warm air blanket and a fluid warmer where necessary.
    All surgical procedures were performed by one surgeon 
through a median sternotomy, and the heart was displaced 
using a posterior pericardial stitch, large (12 × 70 cm) gauze 
swabs and a tissue stabilizer (Rosta
Ⓡ 2.0, Yoorim Corporation, 
Chungbuck, Korea). The sequence of grafting was always 
from the left internal mammary artery to the left anterior des-
cending coronary artery (LAD) first, followed by grafting of 
the circumflex coronary artery (LCx) and right coronary artery 
(RCA) using a composite Y graft consisting of the radial artery 
or saphenous vein with the left internal mammary artery and/
or using the right internal mammary artery where necessary. 
An intracoronary shunt was used on the LAD and distal RCA 
during grafting. All patients were transferred to the intensive 
care unit (ICU) after surgery.
    The preoperative data included age, gender, body mass index, 
as well as the presence of diabetes mellitus, hypertension, or 
chronic renal disease. The other preoperative data included 
cardiac medications, electrocardiography, echocardiographic 
data (left ventricular ejection fraction and E/e’), and volume 
of the radiocontrast solution. The intraoperative data obtained 
included the duration of anaesthesia and the number of grafts 
performed. In the ICU, the following variables were recorded: 
postoperative day one blood loss, duration of ventilation, length 
of ICU stay and length of hospital stay. Also included were 
the occurrence of re-intubation, the need for hemostatic re-
exploration, and the occurrence of postoperative atrial fibril-
lation and/or death. 
    The serum creatinine (SCr), serum cystatin C and estimated 
glomerular filtration rate (eGFR) were obtained one day 
before surgery and on postoperative days (POD) 1, 2, 3 and 7. 
This information was used to evaluate the renal function. The 
postoperative AKI was diagnosed if there was ≥50% or ≥0.3 
mg/dl increase in the serum creatinine level within 48 hours, 
compared to the preoperative baseline value [12].
    Statistical analysis was performed using SPSS 13.0 (SPSS 
Inc., Chicago, IL, USA). Forty-five patients were required in 
each group to produce an 80% power to detect a 0.3 mg/dl 
difference in Cr between the two groups with a SD of 0.5 mg/
dl and an alpha level of 0.05 in an independent t-test [13]. All 
the data is expressed as the mean ± SD, median (interquartile 
range) or number of patients (%) according to the distribution 
of normality. The data between the groups was compared using 
a Chi-square test, Fisher's exact test, independent t-test or a 
Mann–Whitney U-test, where appropriate. Repeated measures 
analysis of variance was performed to compare the changes in 
SCr, cystatin C and eGFR between the groups. A P value < 0.05 
was considered statistically significant.
Results
    In all patients, iopromide (Ultravist
®; Bayer Schering, Seoul, 
Korea) or iodixanol (Visipaque
®; GE Healthcare, Seoul, Korea) 
was used as a contrast agent during coronary angiography. 
The patients’ characteristics including the number of CIN risk 
factors were similar in the two groups (Table 1). In the Angio 
Table 1. Patient Characteristics
Control 
(n = 55)
Angio 
(n = 55)
P value
Age (yr) 65 ± 9 67 ± 8 0.163
Sex (M/F) 41 : 14 41 : 14 1.000
Body mass index (m
2) 24.5 ± 3.0 24.9 ± 2.9 0.451
NYHA grade I–II  48 (87) 44 (80)
              grade III–IV   7 (13) 11 (20) 0.303
Hypertension 41 (75) 48 (87) 0.089
Diabetes mellitus 32 (58) 27 (49) 0.339
Chronic renal disease 1 (2) 2 (4) 1.000
Preoperative hematocrit 37.2 ± 5.4 37.9 ± 4.9 0.491
Elective: emergency surgery 53 : 2 50 : 5 0.438
Number of CIN risk factors     3 (2–3)     2 (2–4) 0.786
Electrocardiography
  (NSR : A–fib)
55 : 0 54 : 1 1.000
LVEF (percent) 55 (36-67) 59 (45-68) 0.247
E/e’ 13 (10-17) 13 (10-17) 0.592
Medications
  ACEI 22 (40) 17 (31) 0.319
  ARB 23 (42) 26 (47) 0.565
  Diuretics 11 (20) 5 (9) 0.105
Number of grafts     3 (3-4)     3 (3-4) 0.881
Duration of anesthesia (min) 302 ± 40 307 ± 49 0.547
Volume of contrast (ml) 123 (100-144) 123 (100-150) 0.467
Values are reported as the mean ± SD, median (interquartile range) 
or number of patients (%). Control: coronary angiography performed 
within two days of OPCAB, Angio: coronary angiography performed 
more than two days before OPCAB, NYHA: New York Heart Associa-
tion, LVEF: left ventricular ejection fraction, CIN: contrast-induced 
nephropathy, NSR: normal sinus rhythm, A-fib: atrial fibrillation, 
ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotension 
receptor blocker.145 www.ekja.org
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group, 5, 17 and 33 patients received coronary angiography on 
the same day of surgery, one day and two days before surgery, 
respectively. In the Control group, coronary angiography was 
performed three to 69 days before OPCAB. 
    Intraoperative fluid management, transfusion or the use 
of vasopressors that can affect postoperative renal function 
were similar in the two groups (Table 2). The preoperative SCr, 
cystatin C and eGFR were similar in the two groups throughout 
the study period (Table 3). Fig. 1 shows the incidence of post-
operative AKI and renal replacement therapy. Eight (15%) 
patients in the Control group and ten (18%) patients in the 
Angio group developed AKI. One patient in the Control group 
and four patients in the Angio group required renal replacement 
therapy postoperatively. Although the Angio group had a higher 
incidence of AKI and renal replacement therapy, it was not 
statistically significant (P = 0.667 and 0.363, respectively). 
    The median duration of the ICU stay was significantly longer 
in the Angio group than the Control group [52.0 (IQR 48.0–75.0) 
vs. 48.9 (IQR 44.8–71.3) h, P = 0. 048], even though the duration 
of the hospital stay was similar (Table 4). There were no signi-
ficant differences in the other postoperative outcomes. 
Discussion
    This study examined the effect of the time interval between 
coronary angiography and OPCAB on the postoperative renal 
function. Coronary angiography performed within two days 
before OPCAB did not adversely affect the postoperative renal 
function in terms of the postoperative SCr, cystatin C and 
eGFR levels or the incidence of postoperative AKI. Since CIN 
develops within 48 hours after angiography [11], the incidence 
of postoperative renal dysfunction was expected to be higher in 
those patients who had undergone angiography within two days 
of OPCAB. These findings are in contrast to previous studies 
with patients undergoing CABG using CPB [5,14]. Although 
cardiac surgery is generally performed or postponed for days 
or weeks after coronary angiography because of the concerns 
about the development of CIN, the results of this study suggest 
that choosing to delay OPCAB due to the limited passage of 
time since coronary angiography might not be necessary in 
patients with a preoperatively normal renal function.
    A renal dysfunction is one of the most common and serious 
Table  2. Intraoperative Administration of Fluid and Red Blood Cell 
and the Use of Vasopressor
Control (n = 55) Angio (n = 55) P value
Crystalloid amount (ml) 2,300 
(1,800-2,600)
2,500 
(2,200-2,900)
0.104
Colloid amount (ml) 1,300 
(1,200-1,500)
1,300 
(1,100-1,500)
0.347
Total fluid amount (ml) 3,650 
(3,100-4,100)
3,800 
(3,200-4,300)
0.225
RBC transfusion  21 (38%) 19 (35%) 0.632
Urine output (ml) 520 (345-760) 660 (420-900) 0.102
Use of vasopressor 53 (96%) 53 (96%) 1.000
Values are reported as the median (interquartile range) or number of 
patients (%). Control: coronary angiography performed within two 
days of OPCAB, Angio: coronary angiography performed more than 
two days before OPCAB.
Table 3. Changes in the Serum Creatinine, Cystatin C, and Estimated GFR Levels during the Perioperative Period
Group Pre-operation POD 1 POD 2 POD 3 POD 7
Serum Cr (mg/dl) Control 1.00 (0.85-1.20) 1.00 (0.80-1.20) 1.04 (0.90-1.27) 1.08 (0.93-1.33) 1.00 (0.86-1.18)
Angio 0.99 (0.88-1.20) 0.95 (0.79-1.21) 1.03 (0.83-1.39) 1.11 (0.86-1.11) 1.04 (0.90-1.31)
Serum cystatin C (mg/L) Control 0.83 (0.74-0.97) 0.67 (0.57-0.81) 0.78 (0.66-1.00) 0.85 (0.70-0.99) 0.85 (0.75-1.03)
Angio 0.85 (0.67-1.03) 0.77 (0.56-0.94) 0.84 (0.62-1.17) 0.94 (0.74-1.15) 1.06 (0.79-1.30)
eGFR (ml/min/1.73 m
2) Control 74.5 (61.0-87.1) 73.3 (59.3-98.8) 70.3 (57.1-82.2) 71.5 (52.9-83.2) 76.8 (62.2-88.8)
Angio 74.6 (57.9-87.9) 77.1 (58.8-98.9) 68.9 (51.1-91.2) 69.1 (47.9-89.7) 69.5 (51.5-86.9)
Values are reported as the median (interquartile range). Control: coronary angiography performed within two days of OPCAB, Angio: coronary 
angiography performed more than two days before OPCAB, Cr: creatinine, eGFR: estimated glomerular filtration rate, POD: postoperative day.
Fig. 1.  Incidence of acute kidney injury and renal replacement 
therapy. Control: coronary angiography performed within two days 
of OPCAB, Angio: coronary angiography performed more than two 
days before OPCAB, AKI: acute kidney injury, RRT: renal replacement 
therapy.146 www.ekja.org
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complications after CABG [1-4]. Even small increases in SCr are 
associated with increased mortality [1-3]. The most important 
factors contributing to postoperative renal dysfunction after 
cardiac surgery are the use of CPB and other factors associated 
with using CPB [4]. Therefore, despite the controversy, OPCAB 
performed without CPB is expected to have a positive effect 
on the postoperative renal function. The incidence of AKI was 
lower in OPCAB patients than in those who had undergone 
CABG using CPB (14% vs. 24%) [15]. These findings are 
comparable to the results of this study, but higher than the 
7.5% of non-cardiac surgery [16]. Recently, a definition of AKI 
was established by the consensus of all key critical care and 
nephrology societies worldwide [12], and the new definition of 
AKI was applied in this study. The possible reason for the renal 
dysfunction after OPCAB was attributed to the impaired renal 
perfusion during distal anastomosis of the lateral and posterior 
vessels requiring verticalization of the heart and a resulting 
outflow tract obstruction and low cardiac output [17]. 
    One of the new concerns in renal dysfunction after cardiac 
surgery is the timing of coronary angiography, because 
coronary angiography can affect the renal function. The SCr 
level begins to increase within 24 h of contrast administration 
and usually peaks within 3–5 days [18]. Therefore, the timing of 
coronary angiography can affect the postoperative SCr levels. 
Few studies have evaluated the impact of coronary angiography 
on the postoperative renal function in cardiac surgery using 
CPB [5,10,14]. In two of these studies, the same day surgery 
and coronary angiography [14], and coronary angiography 
performed within 5 days before surgery [5] increased the peak 
postoperative SCr levels and the risk of ARF. However, in a report 
from the Mayo Clinic [10], same-day coronary angiography 
had little impact on the renal function for patients undergoing 
elective valvular heart surgery. The much shorter duration of 
CPB (48 ± 20 min) compared to the former studies might have 
little impact on the renal function in that study. Postoperative 
renal dysfunction after cardiac surgery was closely related to the 
duration of CPB [5]. The subsequent exposure to CPB after the 
use of a contrast agent can have a synergistically adverse effect 
on the postoperative renal function. Therefore, the impact of 
the timing of angiography might be different between cardiac 
surgery using CPB and OPCAB. The differences in patient selec-
tion can also contribute to the differences in the results. In 
this study, patients with a preoperative SCr level exceeding 1.8 
mg/dl were excluded, which is unlike previous studies which 
excluded only those patients on dialysis before surgery [5,14]. 
On the other hand, in the present study, patients with at least 
two risk factors for CIN were included in order to focus more on 
the impact of exposure to the radiocontrast on the postoperative 
renal function. 
    Although SCr was used as a guide for a diagnosis of AKI, eGFR 
was also evaluated as a renal function index, as in previous 
studies [5,14]. The cystatin C levels were also monitored. The 
SCr levels are strongly influenced by the muscle mass, and eGFR 
is not optimal in people with normal SCr levels [19]. However, 
eGFR was recommended as an appropriate renal function 
measure by the National Kidney Foundation [20]. Cystatin C is 
believed to overcome some of the limitations of SCr and eGFR, 
as it does not depend on age, gender or body mass. However, 
AKI has not been defined using the cystatin C levels. In patients 
with AKI, the cystatin C levels increased before SCr and allowed 
for the detection of AKI one to two days earlier than SCr [21]. 
In this study, there were no differences in the cystatin C levels 
during the postoperative period between the two groups. 
    Contrast media are commonly divided into high-osmolar, 
low-osmolar and iso-osmolar. Iopromide is one of the low-
osmolar contrast media. Meta-analysis suggests that low-
osmolar contrast media caused a smaller decrease in renal 
function than the high-osmolar contrast media [22]. In addition, 
it was demonstrated that the iso-osmolar contrast media 
(iodixanol) exhibits lower nephrotoxic properties than the low-
osmolar media in a population of patients at very high risk [23]. 
In this study, two types of radiocontrast, iopromide or iodixanol, 
were used in the patients. The use of less nephrotoxic contrast 
media might be a possible reason for little impact of the timing 
of angiography on AKI. The prophylaxis strategy for CIN (e.g., 
adequate hydration, minimal volume of iso-osmolar or low-
osmolar contrast, N-acetylcystein) can be helpful in reducing 
the incidence of AKI in patients with the risk factors for CIN 
[24]. Moreover, considering that the incidence of AKI was still 
high in this study, careful compression and positioning of the 
heart during distal anastomosis to minimize hemodynamic 
Table 4. Postoperative Outcomes
Control (n = 55) Angio (n = 55) P value
Duration of ventilation in
  ICU (h)
17.2 
(15.4-18.0)
17.7 
(14.5-19.0)
0.704
Duration of ICU stay (h) 48.9 
(44.8-71.3)
52.0 
(48.0-75.0)*
0.048
Duration of hospital stay
   after operation (d)
9.0 
(9.0-12.5)
9.0 
(7.0-10.0)
0.122
Re-intubation 1 (2) 1 (2) 1.000
Hemostatic re-exploration 0 1 (2) 1.000
Death 1 (2) 2 (4) 1.000
Postoperative day 1 blood
  loss
980 (720–1,330) 810 (530–1,025) 0.098
Postoperative A-fib 3 (6) 8 (15) 0.122
Values are reported as the mean ± SD, median (interquartile range) 
or number of patients (%). Control: coronary angiography performed 
within two days of OPCAB, Angio: coronary angiography performed 
more than two days before OPCAB, A-fib: atrial fibrillation. *P < 0.05 
versus control group.147 www.ekja.org
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instability and maintain adequate renal perfusion [17] might be 
more important for reducing the incidence of AKI in patients 
undergoing OPCAB than the timing of angiography. 
    This study was limited by potentially confounding information 
and selection bias, which are the same pitfalls encountered 
in previous studies. However, previous studies [5,10,14] did 
not mention important factors, such as intraoperative fluid 
management, transfusion or use of vasopressors, which can 
affect postoperative renal function. This study controlled 
the possible factors affecting renal functions according to 
institutional guidelines. The sample size was calculated ac-
cording to the difference in SCr, and might be too small to allow 
for the detection of differences in the incidence of AKI and renal 
replacement therapy (RRT). Despite the similar postoperative 
outcome variables, the patients in the Angio group stayed 
longer in the ICU than the Control group. Although the precise 
reason for this longer ICU stay could not be identified, it might 
be due to a trend of more frequent RRT in the Angio group 
because RRT is a well known contributing factor for a prolonged 
stay in the ICU. Indeed, the duration of the ICU stay was similar 
in the two the groups when the patients undergoing RRT were 
excluded (P = 0.092).  
    In conclusion, coronary angiography performed within 
two days before OPCAB did not affect the postoperative renal 
function and incidence of AKI in patients with a preoperatively 
normal renal function. These findings suggest that there is no 
need to delay OPCAB after using a radiocontrast agent due to 
the concern of AKI in patients with a preoperatively normal 
renal function.
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